Cantel Medical (CMD) stock price, revenue, and financials

Cantel Medical market cap is $3.4 b, and annual revenue was $918.16 m in FY 2019

$3.4 B

CMD Mkt cap, 04-Jun-2021

$277.5 M

Cantel Medical Revenue Q3, 2021
Cantel Medical Gross profit (Q3, 2021)136.7 M
Cantel Medical Gross profit margin (Q3, 2021), %49.2%
Cantel Medical Cash, 30-Apr-2021218.5 M
Cantel Medical EV4.1 B
Get notified regarding key financial metrics and revenue changes at Cantel MedicalLearn more
Banner background

Cantel Medical Revenue Breakdown

Embed Graph

Cantel Medical revenue breakdown by business segment: 22.8% from Water Purification and Filtration, 19.4% from Healthcare Disposables, 53.7% from Endoscopy and 4.1% from Other

Cantel Medical revenue breakdown by geographic segment: 77.9% from United States, 5.3% from Asia/Pacific, 12.4% from Europe/Africa/Middle East and 4.4% from Other

Cantel Medical Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

488.7m565.0m664.8m770.2m918.2m

Revenue growth, %

16%18%16%

Cost of goods sold

275.5m311.5m355.6m403.0m458.0m490.7m

Gross profit

213.3m253.5m309.2m367.2m427.5m

Gross profit Margin, %

44%45%47%48%47%

Sales and marketing expense

99.1m116.1m129.6m140.2m

R&D expense

15.4m18.4m24.6m31.3m

General and administrative expense

97.5m122.3m138.0m172.4m

Operating expense total

112.9m256.8m292.3m343.9m

EBIT

70.9m80.8m97.3m110.4m121.7m83.5m

EBIT margin, %

15%14%15%14%9%

Interest expense

2.4m2.4m3.3m4.3m5.3m9.5m

Interest income

63.0k68.0k

Pre tax profit

68.6m76.2m93.9m106.2m117.5m75.3m

Income tax expense

25.3m28.2m34.0m34.9m26.5m20.3m

Net Income

43.3m48.0m60.0m71.4m91.0m55.0m

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

93.3m97.3m97.2m99.7m106.4m105.0m118.3m119.0m120.1m136.8m135.4m141.5m153.8m158.3m173.7m187.7m184.8m192.1m212.8m425.8m643.1m225.6m224.5m228.6m257.2m256.9m207.7m297.0m261.1m277.5m

Cost of goods sold

55.3m56.5m54.6m56.0m61.2m59.5m66.8m66.7m67.6m76.3m74.8m77.9m82.6m85.9m93.4m98.2m96.3m100.7m112.1m223.9m336.5m120.3m119.9m121.7m141.4m144.9m116.5m149.7m132.1m140.8m

Gross profit

38.0m40.8m42.6m43.7m45.2m45.5m51.5m52.3m52.4m60.5m60.6m63.6m71.2m72.3m80.3m89.5m88.5m91.4m100.7m201.9m306.6m105.2m104.7m106.9m115.9m112.0m91.2m147.4m129.0m136.7m

Gross profit Margin, %

41%42%44%44%42%43%44%44%44%44%45%45%46%46%46%48%48%48%47%47%48%47%47%47%45%44%44%50%49%49%

Sales and marketing expense

12.9m13.3m14.2m13.4m13.7m15.1m15.8m16.1m16.5m19.4m19.3m20.3m21.5m22.6m26.9m27.9m26.9m30.5m31.6m62.5m95.8m34.0m33.2m36.1m38.4m40.1m

R&D expense

2.1m2.3m2.2m2.3m2.2m2.4m2.3m2.5m2.6m3.5m3.2m3.5m3.8m3.1m4.1m4.5m4.5m4.3m5.3m11.0m17.5m7.1m7.9m7.4m7.7m7.6m

General and administrative expense

12.1m12.1m12.4m12.0m12.4m13.8m15.2m15.6m16.4m18.5m19.8m18.5m22.2m22.3m26.1m30.0m28.5m29.2m32.1m64.3m102.1m36.5m37.4m48.6m55.3m49.4m

Operating expense total

27.2m27.7m28.8m27.8m28.3m31.3m33.2m34.1m35.6m41.5m42.3m42.3m47.4m47.9m57.1m62.4m59.9m64.0m69.0m137.8m215.4m77.6m78.5m92.1m101.4m97.0m

EBIT

10.8m13.2m13.8m16.0m16.9m14.2m18.3m18.2m16.8m19.0m18.3m21.3m23.8m24.4m23.3m27.1m28.6m27.4m31.6m64.1m91.2m27.7m26.2m14.8m14.4m50.4m

EBIT margin, %

12%14%14%16%16%14%15%15%14%14%14%15%15%15%13%14%15%14%15%15%14%12%12%6%6%17%

Interest expense

1.0m1.0m897.0k646.0k791.0k749.0k657.0k645.0k552.0k550.0k661.0k636.0k766.0k893.0k890.0k1.1m1.1m1.1m1.2m2.3m3.8m2.0m2.2m2.5m5.7m16.3m

Interest income

30.0k24.0k13.0k13.0k16.0k16.0k13.0k15.0k17.0k16.0k15.0k17.0k21.0k22.0k19.0k19.0k24.0k

Pre tax profit

9.8m11.6m12.9m15.3m16.1m13.5m17.7m17.6m16.3m18.5m17.7m18.5m23.0m23.5m22.4m26.0m27.5m26.4m31.6m62.9m88.5m25.7m25.3m12.3m8.7m34.1m

Income tax expense

3.6m4.3m4.7m5.8m5.6m4.5m6.5m6.5m6.0m7.3m6.6m6.1m8.8m8.1m8.4m7.2m9.4m8.8m8.7m7.5m14.3m6.4m6.5m4.1m2.9m9.6m

Net Income

6.2m7.3m8.2m9.6m10.5m9.0m11.2m11.1m10.2m11.2m11.1m12.4m14.3m15.4m14.0m18.8m18.1m17.5m22.9m55.4m74.2m19.2m18.8m8.2m5.8m24.5m

Cantel Medical Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

30.2m34.1m31.8m31.7m28.4m36.6m94.1m44.5m

Accounts Receivable

48.0m52.8m93.3m110.7m118.6m146.9m

Prepaid Expenses

3.3m4.4m9.6m11.4m17.9m20.9m

Inventories

46.8m54.2m59.7m8.5m91.5m98.7m107.6m138.2m

Current Assets

133.9m150.7m163.9m188.4m222.7m257.4m338.2m351.8m

PP&E

43.0m46.5m52.7m62.5m74.6m88.3m111.4m185.2m

Goodwill

183.7m211.6m231.6m242.0m280.3m311.4m368.0m378.1m

Total Assets

434.8m487.7m536.1m584.0m694.5m786.4m963.7m1.1b

Accounts Payable

12.3m13.3m19.5m16.2m26.3m27.5m34.3m39.5m

Short-term debt

10.0m10.0m10.0m10.0m

Current Liabilities

55.1m59.2m66.5m70.6m96.3m106.8m134.8m151.4m

Long-term debt

80.0m85.0m80.5m78.5m116.0m126.0m187.3m220.9m

Total Debt

90.0m95.0m80.5m78.5m116.0m126.0m197.3m230.9m

Total Liabilities

240.2m262.4m354.8m408.8m

Common Stock

3.0m4.5m4.6m4.6m

Preferred Stock

Additional Paid-in Capital

127.3m134.9m146.0m156.1m165.6m174.6m184.2m204.8m

Retained Earnings

167.5m203.8m243.3m287.1m342.1m407.6m491.5m539.1m

Total Equity

275.9m321.1m365.2m406.6m454.4m523.9m608.9m661.5m

Debt to Equity Ratio

0.3 x0.2 x0.2 x0.3 x0.2 x0.3 x0.3 x

Debt to Assets Ratio

0.2 x0.2 x0.1 x0.2 x0.2 x0.2 x0.2 x

Financial Leverage

1.6 x1.5 x1.5 x1.4 x1.5 x1.5 x1.6 x1.6 x

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

19.6m21.7m25.0m27.9m26.8m30.7m28.5m19.7m24.5m29.7m24.1m25.4m31.1m21.6m25.5m26.1m24.4m30.9m37.2m40.0m51.9m64.0m71.0m51.3m49.3m58.7m115.8m258.0m243.1m218.5m

Accounts Receivable

43.7m45.9m46.3m48.8m52.3m52.1m100.1m125.1m127.1m142.5m174.9m168.9m147.6m158.8m159.4m164.9m

Prepaid Expenses

5.5m4.5m4.0m5.2m5.1m4.5m13.1m17.3m21.8m23.0m25.2m26.0m21.8m19.4m22.4m23.9m

Inventories

46.1m46.8m47.5m47.6m48.7m52.9m55.3m56.2m56.5m60.2m65.2m69.9m78.6m79.4m90.9m96.8m96.2m102.8m105.8m111.4m113.1m111.1m115.9m134.2m200.3m184.2m185.5m163.9m170.1m179.1m

Current Assets

118.6m122.6m126.7m133.2m138.0m145.2m151.3m148.0m152.0m174.0m178.0m181.1m202.4m196.5m225.9m231.0m233.7m257.5m267.7m283.0m300.5m317.6m335.8m352.5m449.7m437.7m486.0m627.1m638.0m626.0m

PP&E

44.2m43.7m43.3m42.4m45.8m45.4m46.6m47.1m48.5m52.9m61.4m61.6m69.2m70.0m72.6m80.5m83.0m85.7m91.5m95.7m100.8m148.6m164.8m173.1m227.9m230.0m224.2m223.5m226.1m227.6m

Goodwill

184.5m183.5m183.7m183.7m208.3m208.2m211.4m218.7m218.9m224.1m235.8m242.5m280.5m277.8m284.0m295.8m302.6m308.2m351.8m358.3m366.8m370.9m371.0m378.1m655.4m656.6m653.6m660.4m665.6m666.2m

Total Assets

429.2m428.7m430.3m431.5m471.9m484.4m485.8m493.2m497.9m558.7m567.7m579.9m677.7m663.3m706.9m749.4m753.2m784.4m855.2m883.7m922.0m983.6m1.0b1.1b1.9b1.9b1.9b2.0b2.1b2.0b

Accounts Payable

11.8m11.9m11.2m13.1m12.7m14.6m14.1m14.7m15.8m17.7m18.2m18.3m14.1m15.7m28.3m30.0m30.0m33.8m28.4m33.8m36.6m42.0m35.1m50.5m40.4m37.7m53.0m46.9m54.2m59.0m

Dividends Payable

1.3m1.5m1.9m2.5m2.9m

Short-term debt

10.0m10.0m10.0m10.0m10.0m10.0m10.0m10.0m10.0m10.0m24.5m29.5m31.4m14.8m22.1m29.5m

Current Liabilities

52.2m51.6m50.7m54.6m51.4m56.3m60.0m47.5m50.2m64.0m62.3m66.2m75.1m66.1m91.3m98.1m92.1m107.3m109.6m109.6m123.3m143.8m122.6m151.1m183.4m204.0m197.9m200.2m234.5m243.0m

Long-term debt

106.5m98.0m90.5m70.0m97.0m95.0m72.0m74.5m64.5m93.5m95.5m91.5m147.5m133.5m132.0m161.0m149.0m145.0m168.0m160.0m169.0m184.9m227.6m223.2m875.8m885.4m944.0m971.8m916.9m862.1m

Total Debt

116.5m108.0m100.5m80.0m107.0m105.0m82.0m74.5m64.5m93.5m95.5m91.5m147.5m133.5m132.0m161.0m149.0m145.0m168.0m160.0m169.0m194.9m237.6m233.2m900.3m914.9m975.4m986.5m939.0m891.6m

Total Liabilities

312.6m297.2m320.7m361.2m380.4m406.9m1.2b1.2b1.2b1.3b1.3b1.2b

Common Stock

2.0m3.0m3.0m3.0m3.0m3.0m4.6m4.6m4.6m4.6m4.7m4.7m4.7m4.7m4.7m4.7m

Preferred Stock

Additional Paid-in Capital

120.0m122.3m124.6m129.2m132.5m133.7m138.7m141.3m143.6m150.7m152.1m153.8m159.2m161.2m163.5m168.5m170.6m172.5m177.4m180.1m183.6m187.1m192.2m201.1m268.0m265.8m240.6m276.5m281.5m285.3m

Retained Earnings

143.7m151.0m159.2m175.6m186.1m195.1m213.1m224.2m234.5m254.5m263.6m275.9m298.9m314.2m328.3m357.9m376.0m393.5m430.5m459.5m478.2m511.6m526.3m534.4m544.9m538.1m553.9m572.8m584.9m606.0m

Total Equity

247.3m256.7m266.4m284.6m298.0m308.0m330.4m342.0m354.4m375.7m380.4m394.2m417.6m427.5m447.6m460.4m483.2m503.9m542.6m586.5m601.3m622.4m641.6m655.9m732.2m723.3m688.5m758.4m787.7m817.2m

Debt to Equity Ratio

0.5 x0.4 x0.4 x0.3 x0.4 x0.3 x0.2 x0.2 x0.2 x0.2 x0.3 x0.2 x0.4 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.4 x0.4 x1.2 x1.3 x1.3 x1.2 x

Debt to Assets Ratio

0.3 x0.3 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.1 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.5 x0.5 x0.5 x0.5 x

Financial Leverage

1.7 x1.7 x1.6 x1.5 x1.6 x1.6 x1.5 x1.4 x1.4 x1.5 x1.5 x1.5 x1.6 x1.6 x1.6 x1.6 x1.6 x1.6 x1.6 x1.5 x1.5 x1.6 x1.6 x1.6 x2.6 x2.6 x2.8 x2.7 x2.6 x2.5 x

Cantel Medical Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

31.3m39.2m43.3m48.0m60.0m71.4m91.0m55.0m

Depreciation and Amortization

15.9m17.3m8.2m10.7m25.1m33.5m34.8m42.4m

Accounts Receivable

2.3m(2.4m)(6.1m)(3.9m)(12.7m)(12.9m)(3.7m)(23.0m)

Inventories

(2.2m)(5.3m)(2.7m)(10.1m)(15.6m)887.0k(3.8m)(28.7m)

Accounts Payable

(177.0k)(1.6m)6.4m(3.3m)17.7m7.0m10.6m13.3m

Cash From Operating Activities

50.6m51.5m64.3m59.1m80.3m108.2m125.9m66.9m

Purchases of PP&E

(5.5m)(6.7m)(37.7m)(95.4m)

Capital Expenditures

(13.5m)(12.8m)(18.9m)(27.1m)

Cash From Investing Activities

(103.1m)(52.0m)(47.4m)(52.3m)(113.0m)(97.1m)(125.2m)(133.0m)

Short-term Borrowings

(22.0m)(30.0m)(208.3m)(7.0m)

Long-term Borrowings

(10.0m)(10.0m)(15.2m)

Dividends Paid

(2.5m)(3.0m)(3.7m)(4.2m)(5.0m)(5.8m)(7.1m)(8.3m)

Cash From Financing Activities

64.5m4.4m(18.9m)(6.1m)29.9m(2.8m)57.1m14.7m

Net Change in Cash

11.8m3.9m(3.4m)8.2m57.5m(49.6m)

Interest Paid

2.9m2.6m5.2m9.3m

Income Taxes Paid

15.5m17.1m3.0m35.3m19.0m

Free Cash Flow

50.7m46.3m61.4m81.1m

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

6.2m13.5m21.7m9.6m20.0m29.0m11.2m11.1m10.2m11.2m11.1m12.4m14.3m15.4m14.0m18.8m36.9m17.5m22.9m55.4m74.2m19.2m38.0m46.2m5.8m3.5m19.3m24.5m36.5m57.7m

Depreciation and Amortization

1.7m3.4m5.1m1.8m3.6m5.4m15.1m4.0m8.2m25.7m10.7m20.1m31.0m6.3m29.2m46.1m17.3m34.5m51.8m

Accounts Receivable

6.6m4.4m4.0m(788.0k)(2.3m)(2.1m)(2.7m)8.6m1.1m892.0k(4.1m)(6.9m)(18.6m)(348.0k)5.7m27.0m(10.3m)(9.7m)(15.0m)

Inventories

(1.9m)(2.3m)(3.0m)(833.0k)(4.0k)(4.3m)(1.0m)(2.6m)(8.1m)(9.8m)(3.4m)(9.5m)(24.7m)(6.3m)(2.2m)(3.5m)4.2m26.0k(8.9m)

Accounts Payable

(3.7m)(6.3m)(8.8m)(3.8m)15.8m17.7m18.2m18.3m14.1m15.7m28.3m30.0m(2.5m)33.8m(6.7m)557.0k13.9m1.1m(10.1m)13.6m(13.7m)(22.7m)(8.6m)10.2m39.3m40.3m

Cash From Operating Activities

7.7m19.8m32.9m9.4m19.1m34.5m45.0m30.1m54.7m90.0m32.3m29.2m48.5m8.9m43.5m92.8m62.0m109.8m145.1m

Purchases of PP&E

(1.3m)(2.5m)(3.9m)(1.2m)(2.5m)(4.0m)(14.4m)(38.8m)(62.1m)(75.4m)(10.4m)(21.1m)(26.2m)(5.5m)(17.0m)(26.9m)

Capital Expenditures

(6.5m)(13.5m)(23.8m)

Cash From Investing Activities

(97.8m)(98.9m)(101.7m)(1.2m)(39.4m)(49.2m)(72.7m)(66.8m)(77.8m)(108.4m)(55.8m)(83.1m)(113.0m)(669.3m)(705.2m)(745.3m)(5.1m)(17.2m)(27.0m)

Short-term Borrowings

(3.0m)(9.0m)(14.0m)(7.5m)(15.0m)(22.5m)(28.0m)(7.0m)(10.9m)(20.9m)(32.9m)(75.0m)(125.0m)(175.0m)

Long-term Borrowings

(2.5m)(5.0m)(7.5m)(2.5m)(5.0m)(7.5m)(2.5m)(5.0m)(12.7m)(2.4m)(5.0m)(12.4m)(103.0k)(224.0k)(349.0k)

Dividends Paid

(1.3m)(1.3m)(1.5m)(1.5m)(2.9m)(3.5m)(3.5m)(4.2m)(4.2m)(4.5m)(4.5m)

Cash From Financing Activities

91.4m82.4m75.6m(10.5m)16.9m15.2m23.8m36.2m24.5m33.2m(6.8m)31.5m21.5m665.2m674.6m726.0m(76.6m)(127.5m)(178.0m)

Net Change in Cash

1.2m3.3m6.6m(2.3m)(3.4m)483.0k(4.0m)(30.1m)(23.1m)(42.7m)4.8m14.2m71.2m(19.8m)(34.8m)(59.3m)

Income Taxes Paid

6.5m6.5m6.0m7.3m6.6m6.1m3.5m(7.3m)(7.7m)

Free Cash Flow

23.6m41.2m66.2m

Cantel Medical Ratios

USDQ1, 2012

Debt/Equity

0.5 x

Debt/Assets

0.3 x

Financial Leverage

1.7 x

Cantel Medical Operating Metrics

Cantel Medical's Backlog was reported to be 72.4m in FY, 2016.
FY, 2015FY, 2016

Backlog

66.87 m72.42 m

Patents (Foreign)

167

Patents (US)

55

Patents Pending

120

Trademarks

1.94 k

Cantel Medical Employee Rating

3.7105 votes
Culture & Values
2.5
Work/Life Balance
3.2
Senior Management
2.5
Salary & Benefits
3
Career Opportunities
2.7
Source